Skip to main content
. 2023 Feb 1;13:1099514. doi: 10.3389/fonc.2023.1099514

Table 3.

Perioperative outcomes between conversion and open groups in unmatched cohort.

Characteristics Conversion
(n=14)
Open
(n=475)
P
Operating time (minute), (median (IQR)) 190.5 (153.25, 306.25) 151 (127, 179) 0.004
Intraoperative bleeding (ml), (median (IQR)) 200 (200, 300) 200 (100, 200) 0.152
Angioplasty, n (%) 3 (21.4) 40 (8.4) 0.224
R0, n (%) 13 (92.9) 402 (84.6) 0.642
LN numbers (median (IQR)) 15.5 (13, 20) 15 (11, 20) 0.600
MLN numbers (median (IQR)) 8 (7, 11.5) 9 (6, 12) 0.849
Pathological T stage, n (%) 0.758
 pT2 12 (85.7) 394 (82.9)
 pT3 2 (14.3) 63 (13.3)
 pT4 0 (0.0) 18 (3.8)
Pathological N stage, n (%) 0.724
 pN0 7 (50.0) 209 (44.0)
 pN1 3 (21.4) 148 (31.2)
 pN2 4 (28.6) 118 (24.8)
ICU stay(day), (median (IQR)) 1.5 (0.25, 3) 1 (0, 3) 0.738
Length of drainage (day), (median (IQR)) 6 (4.25, 7.50) 6 (5, 8) 0.341
Drainage amount (ml), (median (IQR)) 1435 (855, 1972.5) 1670 (1235, 2350) 0.122
LOS (day), (median (IQR)) 7 (6, 8.75) 8 (7, 10) 0.065
Complication in hospital, n (%) 1 (7.1) 97 (20.4) 0.376
Mortality in hospital, n (%) 0 (0.0) 5 (1.1) 0.589
Adjuvant chemotherapy, n (%) 7 (50.0) 220 (46.3) 0.785
Adjuvant radiotherapy, n (%) 4 (28.6) 67 (14.1) 0.259

LN, lymph node; MLN, mediastinal lymph node; ICU, intensive care unit; LOS, length of stay.